Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 14/20 | 0.52 |
| ▸ | CES1 | P23141 | 12/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079583 | 0.83 | AKR1C3 (0.48) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL5493096 | 0.77 | F2 (0.42) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL29468149 | 0.76 | CES2 (0.78) | CES2CES1ALDH1A1PKMHPGD | |
| SCHEMBL2225523 | 0.76 | CES2 (0.78) | CES2CES1ALDH1A1PKMHPGD | |
| SCHEMBL5076702 | 0.76 | TSHR (0.62) | CES2CES1ALDH1A1MEN1KMT2A | |
| SCHEMBL9749593 | 0.74 | CES1 (0.62) | CES2CES1ALDH1A1KDM4EMAPT | |
| SCHEMBL27905652 | 0.74 | CES2 (0.64) | CES2CES1ALDH1A1MAPTHSD17B10 | |
| SCHEMBL1437003 | 0.73 | CYP3A4 (0.48) | ALDH1A1KDM4EMEN1MAPTPKM | |
| SCHEMBL4954501 | 0.73 | CES2 (0.64) | CES2CES1ALDH1A1PKMHPGD | |
| SCHEMBL8064637 | 0.73 | CES2 (0.50) | CES2CES1ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102906215-B | Photochromic material | MITSUBISHI GAS CHEMICAL CO | 2014-11-05 | — | — | CN | disclosed |
| CN-102906215-A | Photochromic material | MITSUBISHI GAS CHEMICAL CO | 2013-01-30 | — | — | CN | disclosed |
| US-20050054664-A1 | Anticholinergics, processes for preparing them and pharmaceutical composition containing them | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054664-A1 | Anticholinergics, processes for preparing them and pharmaceutical composition containing them | CHRM1, CHRM3, CHRM2 | CES2 470/4885CES1 568/4885ALDH1A1 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.